Cargando…
Pharmacokinetic modeling of a novel hypoxia PET tracer [(18)F]HX4 in patients with non-small cell lung cancer
BACKGROUND: [(18)F]HX4 is a promising new PET tracer developed to identify hypoxic areas in tumor tissue. This study analyzes [(18)F]HX4 kinetics and assesses the performance of simplified methods for quantification of [(18)F]HX4 uptake. To this end, eight patients with non-small cell lung cancer re...
Autores principales: | Verwer, E. E., Zegers, C. M. L., van Elmpt, W., Wierts, R., Windhorst, A. D., Mottaghy, F. M., Lambin, P., Boellaard, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153396/ https://www.ncbi.nlm.nih.gov/pubmed/27957730 http://dx.doi.org/10.1186/s40658-016-0167-y |
Ejemplares similares
-
Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer
por: Sanduleanu, Sebastian, et al.
Publicado: (2020) -
Evaluation of tumour hypoxia during radiotherapy using [(18)F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
por: Zegers, Catharina M. L., et al.
Publicado: (2016) -
Repeatability of hypoxia PET imaging using [(18)F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial
por: Zegers, Catharina M. L., et al.
Publicado: (2015) -
[(18)F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials
por: Sanduleanu, Sebastian, et al.
Publicado: (2020) -
State of the art procedures towards reactive [(18)F]fluoride in PET tracer synthesis
por: Haveman, Lizeth Y. F., et al.
Publicado: (2023)